These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1022967)

  • 1. Length of continued treatment of an inactive case of leprosy.
    Dharmendra
    Lepr India; 1976 Jul; 48(3):212-6. PubMed ID: 1022967
    [No Abstract]   [Full Text] [Related]  

  • 2. 4:4 diacetyl-diamino-diphenyl sulphone in the treatment of leprosy.
    Kundu S; Ghosh S
    Bull Calcutta Sch Trop Med; 1972 Apr; 20(2):30-1. PubMed ID: 4666676
    [No Abstract]   [Full Text] [Related]  

  • 3. [In vitro immunologic changes in 4 patients with lepromatous leprosy treated for 1 year with rifampicin and sulfones and left untreated the following year].
    Saint-André P
    Acta Leprol; 1979; (76-77):301-2. PubMed ID: 121849
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of leprosy by sulfones and delayed-action sulfonamides: comparison of therapeutic results in 100 cases].
    Privat Y; Faye I; Bellossi A
    Mars Med; 1968; 105(3):276-80. PubMed ID: 5754252
    [No Abstract]   [Full Text] [Related]  

  • 5. [Polychemotherapy of leprosy in a rural area].
    Languillon J
    Acta Leprol; 1988; 6(5):67-71. PubMed ID: 3271378
    [No Abstract]   [Full Text] [Related]  

  • 6. Maintenance of leprosy endemicity and bacterial positivity of lepromatous patients under treatment with sulfones.
    Bechelli LM; Dominguez VM
    Int J Lepr Other Mycobact Dis; 1971; 39(2):461. PubMed ID: 5169809
    [No Abstract]   [Full Text] [Related]  

  • 7. The treatment of leprosy with the sulfones. I. Faget's original 22 patients. A thirty-year follow-up on sulfone therapy for leprosy.
    Jacobson RR; Trautman JR
    Int J Lepr Other Mycobact Dis; 1971; 39(3):726-37. PubMed ID: 4948221
    [No Abstract]   [Full Text] [Related]  

  • 8. Streptomycin combined with sulfones in the treatment of relapsed lepromatous leprosy.
    Hastings RC; Trautman JR
    Int J Lepr Other Mycobact Dis; 1968; 36(1):45-51. PubMed ID: 5689649
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of leprosy by sulfones and delayed action sulfonamides. Comparison of therapeutic results in 100 cases].
    Faye I; Privat Y; Bellossi A
    Bull Soc Med Afr Noire Lang Fr; 1968; 13(1):119-24. PubMed ID: 5713742
    [No Abstract]   [Full Text] [Related]  

  • 10. The condition of the peripheral nerve in leprosy under various forms of treatment. Conduction velocity studies in long-term follow-up.
    Magora A; Sheskin J; Sagher F; Gonen B
    Int J Lepr Other Mycobact Dis; 1970; 38(2):149-63. PubMed ID: 5529246
    [No Abstract]   [Full Text] [Related]  

  • 11. The promin treatment of leprosy. A progress report.
    Faget GH; Pogge RC; Johansen FA; Dinan JF; Prejean BM; Eccles CG
    Int J Lepr Other Mycobact Dis; 1966; 34(3):298-310. PubMed ID: 5950351
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical stages in sulfone treatment of leprosy.
    Rodriguez JN
    Int J Lepr Other Mycobact Dis; 1970; 38(2):199-203. PubMed ID: 4920411
    [No Abstract]   [Full Text] [Related]  

  • 13. Acedapsone in leprosy treatment: trial in 68 active cases in Micronesia.
    Sloan NR; Worth RM; Jano B; Fasal P; Shepard CC
    Int J Lepr Other Mycobact Dis; 1972; 40(1):48-52. PubMed ID: 4672994
    [No Abstract]   [Full Text] [Related]  

  • 14. [Lights and shadows in the treatment of leprosy].
    Bertaccini G
    G Ital Dermatol Minerva Dermatol; 1966; 107(5):437-46. PubMed ID: 4869129
    [No Abstract]   [Full Text] [Related]  

  • 15. A century of progress in the therapy of leprosy.
    Karat AB; Ramanujam K
    Int J Lepr Other Mycobact Dis; 1973; 41(3):382-91. PubMed ID: 4130572
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on sulfone resistance in leprosy. 2. Treatment with a riminophenazine derivative (B.663).
    Pettit JH; Rees RJ
    Int J Lepr Other Mycobact Dis; 1966; 34(4):391-7. PubMed ID: 6006070
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of leprosy with diucifon].
    Goloshchapov NM; Steklovskiĭ VK; Filipskikh TP; Khromova EB
    Vestn Dermatol Venerol; 1983 Apr; (4):67-71. PubMed ID: 6868818
    [No Abstract]   [Full Text] [Related]  

  • 18. Chemotherapeutic trials in leprosy. 5. A study of methods used in clinical trials in lepromatous leprosy.
    Waters MF; Rees RJ; Sutherland I
    Int J Lepr Other Mycobact Dis; 1967; 35(3):311-35. PubMed ID: 4917107
    [No Abstract]   [Full Text] [Related]  

  • 19. Bacterial negativity and reactivation (relapse) of lepromatous outpatients under sulfone treatment.
    Quagliato R; Bechelli LM; Marques RM
    Int J Lepr Other Mycobact Dis; 1970; 38(3):250-63. PubMed ID: 4993550
    [No Abstract]   [Full Text] [Related]  

  • 20. B.663 and erythema nodosum leprosum.
    Pettit JH
    Int J Lepr Other Mycobact Dis; 1967; 35(3):401-2. PubMed ID: 5630363
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.